Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation

Kristin L.M. Boylan, Benjamin Misemer, Melissa S. DeRycke, John D. Andersen, Katherine M. Harrington, Steve E. Kalloger, C. Blake Gilks, Stefan E. Pambuccian, Amy P.N. Skubitz

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cancer patients and may be involved in tumor progression. We examined claudin 4 expression in ovarian cancer tissues and cell lines, as well as by immunohistochemical staining of tissue microarrays (TMAs; n = 500), spheroids present in patients' ascites, and spheroids formed in vitro. Claudin 4 was expressed in nearly 70% of the ovarian cancer tissues examined and was differentially expressed across ovarian cancer subtypes, with the lowest expression in clear cell subtype. No association was found between claudin 4 expression and disease-specific survival in any subtype. Claudin 4 expression was also observed in multicellular spheroids obtained from patients' ascites. Using an in vitro spheroid formation assay, we found that NIH:OVCAR5 cells treated with shRNA against claudin 4 required a longer time to form compact spheroids compared to control NIH:OVCAR5 cells that expressed high levels of claudin 4. The inability of the NIH:OVCAR5 cells treated with claudin 4 shRNA to form compact spheroids was verified by FITC-dextran exclusion. These results demonstrate a role for claudin 4 and tight junctions in spheroid formation and integrity.

Original languageEnglish (US)
Pages (from-to)1334-1358
Number of pages25
JournalInternational journal of molecular sciences
Volume12
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Claudin-4
spheroids
Ovarian Neoplasms
cancer
Tissue
Dextran
Microarrays
Tumors
cells
Assays
Adhesion
Cells
Association reactions
Molecules
Ascites
Small Interfering RNA
dextrans
staining
Cellular Spheroids
exclusion

Keywords

  • Ascites
  • Biomarker
  • Claudin 4
  • Ovarian cancer
  • Spheroid

Cite this

Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. / Boylan, Kristin L.M.; Misemer, Benjamin; DeRycke, Melissa S.; Andersen, John D.; Harrington, Katherine M.; Kalloger, Steve E.; Gilks, C. Blake; Pambuccian, Stefan E.; Skubitz, Amy P.N.

In: International journal of molecular sciences, Vol. 12, No. 2, 02.2011, p. 1334-1358.

Research output: Contribution to journalArticle

Boylan, Kristin L.M. ; Misemer, Benjamin ; DeRycke, Melissa S. ; Andersen, John D. ; Harrington, Katherine M. ; Kalloger, Steve E. ; Gilks, C. Blake ; Pambuccian, Stefan E. ; Skubitz, Amy P.N. / Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. In: International journal of molecular sciences. 2011 ; Vol. 12, No. 2. pp. 1334-1358.
@article{a3183d06ef2643d59b167d907fac8707,
title = "Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation",
abstract = "Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cancer patients and may be involved in tumor progression. We examined claudin 4 expression in ovarian cancer tissues and cell lines, as well as by immunohistochemical staining of tissue microarrays (TMAs; n = 500), spheroids present in patients' ascites, and spheroids formed in vitro. Claudin 4 was expressed in nearly 70{\%} of the ovarian cancer tissues examined and was differentially expressed across ovarian cancer subtypes, with the lowest expression in clear cell subtype. No association was found between claudin 4 expression and disease-specific survival in any subtype. Claudin 4 expression was also observed in multicellular spheroids obtained from patients' ascites. Using an in vitro spheroid formation assay, we found that NIH:OVCAR5 cells treated with shRNA against claudin 4 required a longer time to form compact spheroids compared to control NIH:OVCAR5 cells that expressed high levels of claudin 4. The inability of the NIH:OVCAR5 cells treated with claudin 4 shRNA to form compact spheroids was verified by FITC-dextran exclusion. These results demonstrate a role for claudin 4 and tight junctions in spheroid formation and integrity.",
keywords = "Ascites, Biomarker, Claudin 4, Ovarian cancer, Spheroid",
author = "Boylan, {Kristin L.M.} and Benjamin Misemer and DeRycke, {Melissa S.} and Andersen, {John D.} and Harrington, {Katherine M.} and Kalloger, {Steve E.} and Gilks, {C. Blake} and Pambuccian, {Stefan E.} and Skubitz, {Amy P.N.}",
year = "2011",
month = "2",
doi = "10.3390/ijms12021334",
language = "English (US)",
volume = "12",
pages = "1334--1358",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation

AU - Boylan, Kristin L.M.

AU - Misemer, Benjamin

AU - DeRycke, Melissa S.

AU - Andersen, John D.

AU - Harrington, Katherine M.

AU - Kalloger, Steve E.

AU - Gilks, C. Blake

AU - Pambuccian, Stefan E.

AU - Skubitz, Amy P.N.

PY - 2011/2

Y1 - 2011/2

N2 - Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cancer patients and may be involved in tumor progression. We examined claudin 4 expression in ovarian cancer tissues and cell lines, as well as by immunohistochemical staining of tissue microarrays (TMAs; n = 500), spheroids present in patients' ascites, and spheroids formed in vitro. Claudin 4 was expressed in nearly 70% of the ovarian cancer tissues examined and was differentially expressed across ovarian cancer subtypes, with the lowest expression in clear cell subtype. No association was found between claudin 4 expression and disease-specific survival in any subtype. Claudin 4 expression was also observed in multicellular spheroids obtained from patients' ascites. Using an in vitro spheroid formation assay, we found that NIH:OVCAR5 cells treated with shRNA against claudin 4 required a longer time to form compact spheroids compared to control NIH:OVCAR5 cells that expressed high levels of claudin 4. The inability of the NIH:OVCAR5 cells treated with claudin 4 shRNA to form compact spheroids was verified by FITC-dextran exclusion. These results demonstrate a role for claudin 4 and tight junctions in spheroid formation and integrity.

AB - Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cancer patients and may be involved in tumor progression. We examined claudin 4 expression in ovarian cancer tissues and cell lines, as well as by immunohistochemical staining of tissue microarrays (TMAs; n = 500), spheroids present in patients' ascites, and spheroids formed in vitro. Claudin 4 was expressed in nearly 70% of the ovarian cancer tissues examined and was differentially expressed across ovarian cancer subtypes, with the lowest expression in clear cell subtype. No association was found between claudin 4 expression and disease-specific survival in any subtype. Claudin 4 expression was also observed in multicellular spheroids obtained from patients' ascites. Using an in vitro spheroid formation assay, we found that NIH:OVCAR5 cells treated with shRNA against claudin 4 required a longer time to form compact spheroids compared to control NIH:OVCAR5 cells that expressed high levels of claudin 4. The inability of the NIH:OVCAR5 cells treated with claudin 4 shRNA to form compact spheroids was verified by FITC-dextran exclusion. These results demonstrate a role for claudin 4 and tight junctions in spheroid formation and integrity.

KW - Ascites

KW - Biomarker

KW - Claudin 4

KW - Ovarian cancer

KW - Spheroid

UR - http://www.scopus.com/inward/record.url?scp=79952259789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952259789&partnerID=8YFLogxK

U2 - 10.3390/ijms12021334

DO - 10.3390/ijms12021334

M3 - Article

C2 - 21541062

AN - SCOPUS:79952259789

VL - 12

SP - 1334

EP - 1358

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 2

ER -